Connable Office Inc Myriad Genetics Inc Transaction History

Connable Office Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 26, 2022	SELL	$18.21 - $27.88 $20,067 - $30,723	-1,102 Reduced 8.03%	12,627 $241,000
Q4 2021 Feb 14, 2022	BUY	$24.13 - $32.63 $26,567 - $35,925	1,101 Added 8.72%	13,729 $379,000
Q2 2021 Aug 06, 2021	SELL	$25.39 - $32.61 $186,311 - $239,292	-7,338 Reduced 36.75%	12,628 $386,000
Q4 2020 Feb 09, 2021	BUY	$12.16 - $19.77 $67,025 - $108,972	5,512 Added 38.13%	19,966 $395,000
Q3 2020 Nov 10, 2020	BUY	$11.25 - $14.75 $4,353 - $5,708	387 Added 2.75%	14,454 $188,000
Q2 2020 Aug 10, 2020	BUY	$10.69 - $16.49 $15,789 - $24,355	1,477 Added 11.73%	14,067 $160,000
Q3 2019 Nov 12, 2019	BUY	$22.08 - $47.08 $277,987 - $592,737	12,590 New	12,590 $360,000

254

90.9M

100K

34K

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.31B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

Stay updated on Connable Office Inc with notifications on news.